Erratum: Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab (British Journal of Cancer (2011) 104 (68-74) DOI: 10.1038/sj.bjc.6605972)

British Journal of Cancer

Volumn 107, Issue 12, 2012, Pages 2024-

  Gualberto, A ^a   Hixon, M L ^a   Karp, D D ^a   Li, D ^a   Green, S ^a   Dolled Filhart, M ^a   Paz Ares, L G ^a   Novello, S ^a   Blakely, J ^a   Langer, C J ^a   Pollak, M N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 84870792537     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.497     Document Type: Erratum

References (0)